The X protein of hepatitis B virus coactivates potent activation domains

Transactivation by hepatitis B virus X protein (pX) is promiscuous, but it requires cellular activators. To study the mode of action of pX, we coexpressed pX with Gal4-derived activators in a cotransfection system. Twelve different activators bearing different types of activation domains were compared for their response to pX. Because pX indirectly increases the amount of the activators, tools were developed to compare samples with equivalent amount of activators. We demonstrate that pX preferentially coactivates potent activators, especially those with acidic activation domains. Weak activators with nonacidic activation domains are not potentiated by pX. Interestingly, Gal4E1a, which is not rich in acidic residues but interacts with similar molecular targets, also responds to pX. The response to pX correlated with the strength of the activation domain. Collectively, these data imply that pX is a coactivator, which offers a molecular basis for the pleiotropic effects of pX on transcription.

[1]  Y. Shaul,et al.  Functional and structural similarity between the X protein of hepatitis B virus and nucleoside diphosphate kinases , 1994, FEBS letters.

[2]  Y. Shaul,et al.  The X protein of hepatitis B virus has a ribo/deoxy ATPase activity. , 1994, Virology.

[3]  C. Harris,et al.  Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Zoulim,et al.  Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.

[5]  S. Kaneko,et al.  Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. , 1994, Virology.

[6]  K. Koike,et al.  Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. , 1994, Oncogene.

[7]  G. Natoli,et al.  Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX , 1994, Molecular and cellular biology.

[8]  R. Tjian,et al.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Yaniv,et al.  Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. , 1994, The EMBO journal.

[10]  Michael R. Green,et al.  Eukaryotic activators function during multiple steps of preinitiation complex assembly , 1993, Nature.

[11]  R. Tjian,et al.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB , 1993, Cell.

[12]  M. Yaniv,et al.  A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. , 1993, The EMBO journal.

[13]  R. Rousset,et al.  Functional and biochemical interaction of the HTLV‐I Tax1 transactivator with TBP. , 1993, The EMBO journal.

[14]  C. Kedinger,et al.  Rb may act as a transcriptional co-activator in undifferentiated F9 cells. , 1993, Oncogene.

[15]  D. Reinberg,et al.  DNA topoisomerase I is involved in both repression and activation of transcription , 1993, Nature.

[16]  W. Rutter,et al.  Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Scheffner,et al.  Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression , 1993, Molecular and cellular biology.

[18]  A. Berk,et al.  Functional interaction of adenovirus E1A with holo-TFIID. , 1993, Genes & development.

[19]  A. Aronheim,et al.  The E2A gene product contains two separable and functionally distinct transcription activation domains. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[21]  Michael R. Green,et al.  Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation , 1993, Nature.

[22]  G. Natoli,et al.  The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. , 1993, Oncogene.

[23]  M. Carlson,et al.  The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. , 1993, Genes & development.

[24]  R. Anderson,et al.  The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks , 1993, Journal of virology.

[25]  M. Karin,et al.  JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. , 1993, Genes & development.

[26]  P. Hofschneider,et al.  Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway , 1993, Nature.

[27]  M. Gilman.  Pleiotropy and henchman X , 1993, Nature.

[28]  P. Chambon,et al.  Distinct TFIID complexes mediate the effect of different transcriptional activators. , 1993, The EMBO journal.

[29]  R. Tjian,et al.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators , 1993, Cell.

[30]  Jun Wu,et al.  Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL- VP16 and the two nonacidic activation functions of the estrogen receptor , 1993, Nucleic Acids Res..

[31]  M. Lai,et al.  Activation of protooncogene c-jun by the X protein of hepatitis B virus. , 1993, Virology.

[32]  M. Gilman.  Viral transactivation. Pleiotropy and henchman X. , 1993, Nature.

[33]  P. Hofschneider,et al.  The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. , 1993, Research in virology.

[34]  P. Angel,et al.  A common intermediary factor (p52/54) recognizing "acidic blob"-type domains is required for transcriptional activation by the Jun proteins , 1992, Molecular and cellular biology.

[35]  J. T. Kadonaga,et al.  Mechanism of transcriptional antirepression by GAL4-VP16. , 1992, Genes & development.

[36]  J. Vierling,et al.  Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  I. Willis,et al.  PCF4 encodes an RNA polymerase III transcription factor with homology to TFIIB , 1992, Cell.

[38]  Qiang Zhou,et al.  Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. , 1992, Genes & development.

[39]  J. T. Kadonaga,et al.  Threshold phenomena and long-distance activation of transcription by RNA polymerase II. , 1992, Science.

[40]  D. Reinberg,et al.  Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription , 1992, Cell.

[41]  W. Caselmann,et al.  Hepatitis B virus transactivator MHBst: activation of NF‐kappa B, selective inhibition by antioxidants and integral membrane localization. , 1992, The EMBO journal.

[42]  Kevin Struhl,et al.  The TATA-binding protein is required for transcription by all three nuclear RNA polymerases in yeast cells , 1992, Cell.

[43]  G. Natoli,et al.  Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator. , 1992, Virology.

[44]  P. Rigby,et al.  A role for the TATA-box-binding protein component of the transcription factor IID complex as a general RNA polymerase III transcription factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Rossner.  Hepatitis B virus X‐gene product: A promiscuous transcriptional activator , 1992, Journal of medical virology.

[46]  R. Lucito,et al.  Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C , 1992, Journal of virology.

[47]  G. Natoli,et al.  The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors. , 1992, Archives of virology. Supplementum.

[48]  R. Tjian,et al.  Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. , 1991, Genes & development.

[49]  A. Berk,et al.  Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor , 1991, Cell.

[50]  B. Luber,et al.  Multiple simian virus 40 enhancer elements mediate the trans-activating function of the X protein of hepatitis B virus. , 1991, Virology.

[51]  S. Murakami,et al.  Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. , 1991, The Journal of biological chemistry.

[52]  D. Luk,et al.  Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains , 1991, Molecular and cellular biology.

[53]  D. Reinberg,et al.  Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Shales,et al.  Reduced binding of TFIID to transcriptionally compromised mutants of VP16 , 1991, Nature.

[55]  M. Perricaudet,et al.  Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. , 1991, Biochemical and biophysical research communications.

[56]  A. Siddiqui,et al.  HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions , 1991, Science.

[57]  Roger D. Kornberg,et al.  A mediator required for activation of RNA polymerase II transcription in vitro , 1991, Nature.

[58]  K. Koike,et al.  X Protein of Hepatitis B Virus Resembles a Serine Protease Inhibitor , 1990, Japanese journal of cancer research : Gann.

[59]  M. Horikoshi,et al.  Recombinant yeast TFIID, a general transcription factor, mediates activation by the gene-specific factor USF in a chromatin assembly assay. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Tjian,et al.  Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: Differences between v- and c-Jun , 1990, Cell.

[61]  A. Siddiqui,et al.  Trans-activation of HLA-DR gene by hepatitis B virus X gene product. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Ou,et al.  Activation of class I major histocompatibility complex gene expression by hepatitis B virus , 1990, Journal of virology.

[63]  M. Ptashne,et al.  Activators and targets , 1990, Nature.

[64]  Michael R. Green,et al.  Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets , 1990, Nature.

[65]  Robert Tjian,et al.  Mechanism of transcriptional activation by Sp1: Evidence for coactivators , 1990, Cell.

[66]  B. Lewin.  Commitment and activation at pol II promoters: A tail of protein-protein interactions , 1990, Cell.

[67]  C. Ingles,et al.  Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID , 1990, Nature.

[68]  Y. Shaul,et al.  The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. , 1990, Oncogene.

[69]  G. Natoli,et al.  Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2 , 1990, Journal of virology.

[70]  T. Unger,et al.  The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. , 1990, The EMBO journal.

[71]  M. Karin,et al.  Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription. , 1990, The New biologist.

[72]  Y. Shaul,et al.  A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli , 1990, Journal of virology.

[73]  P. Mitchell,et al.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors , 1990, Nature.

[74]  B. Aufiero,et al.  The hepatitis B virus X‐gene product trans‐activates both RNA polymerase II and III promoters. , 1990, The EMBO journal.

[75]  D. Chasman,et al.  Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro , 1989, Molecular and cellular biology.

[76]  D. Ganem,et al.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication , 1989, Journal of virology.

[77]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[78]  W. Robinson,et al.  Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Siddiqui,et al.  trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. , 1989, Virology.

[80]  Michael R. Green,et al.  Transcription activation by the adenovirus E1a protein , 1989, Nature.

[81]  M. Ptashne.  How eukaryotic transcriptional activators work , 1988, Nature.

[82]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[83]  D. Spandau,et al.  trans-activation of viral enhancers by the hepatitis B virus X protein , 1988, Journal of virology.

[84]  P. Sharp,et al.  A high-efficiency HeLa cell nuclear transcription extract. , 1988, DNA.

[85]  A. Siddiqui,et al.  Expression of the hepatitis B virus X gene in mammalian cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[86]  H. Varmus,et al.  The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.

[87]  F. Galibert,et al.  The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. , 1985, The EMBO journal.

[88]  R. Lerner,et al.  Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. , 1985, Science.

[89]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .